Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
Boston Scientific (NYSE:BSX) has completed the acquisition of Nalu Medical, expanding its presence in chronic pain treatment. The company has announced a pending US$14.5b deal for Penumbra, which would significantly increase its scale in neurovascular devices. These transactions represent a major reshaping of BSX's portfolio in neuromodulation and neurovascular care. Boston Scientific is a large medical device company with products across cardiology, peripheral interventions, urology and neuromodulation. By adding Nalu Medical and pursuing Penumbra, BSX is leaning further into neurovascular and chronic pain care, areas that sit alongside its existing implantable and minimally invasive technologies. For you as an investor, these moves highlight where management is choosing to commit capital within the broader medtech industry. The integration of Nalu Medical and the outcome of the Penumbra deal could influence BSX's product mix, margin profile and exposure to different procedu
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) was given a new $115.00 price target on by analysts at National Bankshares, Inc..MarketBeat
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- How Surging Heart-Device Demand And Margin Gains At Boston Scientific (BSX) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Stock: Analyst Estimates & Ratings [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/21/26 - Form 425
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- BSX's page on the SEC website